TCT 2015 Late-breaking Trials Announced

August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2015 scientific symposium. TCT has chosen 20 studies that will impact the care of patients and how physicians think about cardiovascular disease. TCT, a premier educational meeting specializing in interventional cardiovascular medicine, will take place Oct. 11-15, 2015, in San Francisco, Calif.

Every year, TCT features major medical research breakthroughs and highlights the latest data on the most innovative treatments that are currently or soon to be available to patients. The studies selected will examine the effectiveness and safety of minimally invasive techniques, pharmaceuticals, technologies, and devices that show potential to treat or prevent cardiovascular disease, the leading cause of death in the world. Late-breaking clinical trials and first report investigations will be presented in the Main Arena and highlighted during press conferences scheduled for Monday, Oct. 12; Tuesday, Oct. 13; Wednesday, Oct. 14; and Thursday, Oct. 15.

The complete agenda for TCT 2015 is also available online. Browse through a wide array of topics and learn more about individual sessions, presentations and faculty on the TCT Web site.

TCT is the annual scientific symposium of CRF. The educational meeting specializes in interventional cardiovascular medicine. For more than 25 years, TCT has featured major medical research breakthroughs and gathered leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.